Literature DB >> 33755744

Patients' poor performance status is an independent risk factor for urosepsis induced by kidney and ureteral stones.

Mika Kino1, Takumi Hayashi2, Daichi Hino2, Takako Nakada2, Hiroki Kitoh2, Koichiro Akakura2.   

Abstract

This study was aimed to identify the risk factors for urosepsis caused by kidney and ureteral stones. One hundred and nine patients who had kidney or ureteral stones and who were treated with trans-ureteral lithotripsy (TUL) at our institution from 2016 to 2020 were included. We investigated the risk factors for urosepsis caused by kidney or ureteral stones that occurred prior to TUL. Thirty patients (28%) had urosepsis prior to TUL. Patients were divided into a urosepsis group (n = 30, 28%) and a non-urosepsis group (n = 79, 72%). Patients' characteristics (gender, age, performance status [PS] score, presence of diabetes mellitus, and skeletal muscle mass), as well as their stone and urine characteristics (stone size, presence of obstructive ureteral stones, stone composition, and urine and stone cultures), were compared between the two groups. When compared to the non-urosepsis group, patients with urosepsis were more likely to be older (p < 0.001), female (p < 0.001), with lower skeletal muscle mass (p < 0.001) and with poor PSs (p < 0.001). For stone and urine characteristics, infection stones (p = 0.01), positive urine (p < 0.001) and stone culture (p = 0.007) were more often detected in patients with urosepsis. A multivariate analysis showed patients' poor PS to be an independent risk factor for urosepsis due to kidney and ureteral stones (OR = 15.7; 95% CI = 2.2-115, p = 0.007). Our study revealed that the most significant risk factor for urosepsis caused by kidney and ureteral stones was the patients' poor PS.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Kidney and ureteral stone; Patients’ performance status; Skeletal muscle mass; Stone culture; Urine culture; Urosepsis

Mesh:

Substances:

Year:  2021        PMID: 33755744     DOI: 10.1007/s00240-021-01256-4

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  30 in total

Review 1.  Infection and urinary stones.

Authors:  Harrison M Abrahams; Marshall L Stoller
Journal:  Curr Opin Urol       Date:  2003-01       Impact factor: 2.309

Review 2.  Urosepsis--Etiology, Diagnosis, and Treatment.

Authors:  Nici Markus Dreger; Stephan Degener; Parviz Ahmad-Nejad; Gabriele Wöbker; Stephan Roth
Journal:  Dtsch Arztebl Int       Date:  2015-12-04       Impact factor: 5.594

Review 3.  Diagnosis and management for urosepsis.

Authors:  Florian M E Wagenlehner; Christoph Lichtenstern; Caroline Rolfes; Konstantin Mayer; Florian Uhle; Wolfgang Weidner; Markus A Weigand
Journal:  Int J Urol       Date:  2013-05-29       Impact factor: 3.369

4.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

5.  Urinary obstruction is an important complicating factor in patients with septic shock due to urinary infection.

Authors:  Karina Reyner; Alan C Heffner; Colleen H Karvetski
Journal:  Am J Emerg Med       Date:  2015-12-23       Impact factor: 2.469

Review 6.  Antibiotic use and the prevention and management of infectious complications in stone disease.

Authors:  Daniel A Wollin; Adrian D Joyce; Mantu Gupta; Michael Y C Wong; Pilar Laguna; Stavros Gravas; Jorge Gutierrez; Luigi Cormio; Kunjie Wang; Glenn M Preminger
Journal:  World J Urol       Date:  2017-02-03       Impact factor: 4.226

7.  Nephrolithiasis and urinary tract infections: 'the chicken or the egg' dilemma?

Authors:  Loris Borghi; Antonio Nouvenne; Tiziana Meschi
Journal:  Nephrol Dial Transplant       Date:  2012-11       Impact factor: 5.992

8.  Ciprofloxacin 250 mg twice daily versus ofloxacin 200 mg twice daily in the treatment of complicated urinary tract infections in women.

Authors:  R Raz; K G Naber; C Raizenberg; Y Rohana; I Unamba-Oparah; G Korfman; I Yaniv
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-05       Impact factor: 3.267

Review 9.  Host-pathogen interactions in sepsis.

Authors:  Tom van der Poll; Steven M Opal
Journal:  Lancet Infect Dis       Date:  2007-12-11       Impact factor: 25.071

10.  Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.

Authors:  Kristina E Rudd; Sarah Charlotte Johnson; Kareha M Agesa; Katya Anne Shackelford; Derrick Tsoi; Daniel Rhodes Kievlan; Danny V Colombara; Kevin S Ikuta; Niranjan Kissoon; Simon Finfer; Carolin Fleischmann-Struzek; Flavia R Machado; Konrad K Reinhart; Kathryn Rowan; Christopher W Seymour; R Scott Watson; T Eoin West; Fatima Marinho; Simon I Hay; Rafael Lozano; Alan D Lopez; Derek C Angus; Christopher J L Murray; Mohsen Naghavi
Journal:  Lancet       Date:  2020-01-18       Impact factor: 202.731

View more
  2 in total

1.  Comprehensive Investigations of Multiple Factors That Are Related to Refractory Outcome in Urosepsis Patients.

Authors:  Takehiro Sejima; Toshihiko Masago; Shuichi Morizane; Masashi Honda; Atsushi Takenaka
Journal:  Yonago Acta Med       Date:  2022-08-29       Impact factor: 1.371

2.  Thromboelastography Parameters in Urosepsis: A Retrospective Study.

Authors:  Yun Qiao; Xiaoye Lu
Journal:  Contrast Media Mol Imaging       Date:  2022-08-17       Impact factor: 3.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.